- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 129-143 of
195 results
1039 Exhibit: Sarafoglou Tildacerfont in Adults with Classic Congenital Adrenal Hyp...
Document
PGR2022-00025, No. 1039 Exhibit - Sarafoglou Tildacerfont in Adults with Classic Congenital Adrenal Hyperplasia Results from Two Phase 2 Studies (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1007 Exhibit: US Patent Application Publication No 20050209250 to Romano
Document
PGR2022-00025, No. 1007 Exhibit - US Patent Application Publication No 20050209250 to Romano (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1026 Exhibit: Webb Current and Novel Approaches to Children and Young People w...
Document
PGR2022-00025, No. 1026 Exhibit - Webb Current and Novel Approaches to Children and Young People with Congenital Adrenal Hyperplasia and Adrenal Insufficiency (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1036 Exhibit: US Patent No 10,849,908 to Alexis Howerton, et al
Document
PGR2022-00025, No. 1036 Exhibit - US Patent No 10,849,908 to Alexis Howerton, et al (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1031 Exhibit: Kehne Therapeutic Utility of Non Peptidic CRF1 Receptor Antagonists...
Document
PGR2022-00025, No. 1031 Exhibit - Kehne Therapeutic Utility of Non Peptidic CRF1 Receptor Antagonists in Anxiety, Depression, and Stress Related Disorders Evidence from Animal Models (P...
|
|
Cite Document
1018 Exhibit: Fahmy Structure and Function of Small Non Peptide CRF Antagonists...
Document
PGR2022-00025, No. 1018 Exhibit - Fahmy Structure and Function of Small Non Peptide CRF Antagonists and their Potential Clinical Use (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1019 Exhibit: Griebel, et al
Document
PGR2022-00025, No. 1019 Exhibit - Griebel, et al (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1003 Exhibit: Application No PCTUS2018046760
Document
PGR2022-00025, No. 1003 Exhibit - Application No PCTUS2018046760 (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1029 Exhibit: Williams, Corticotropin Releasing Factor 1 Receptor Antagonists A Pa...
Document
PGR2022-00025, No. 1029 Exhibit - Williams, Corticotropin Releasing Factor 1 Receptor Antagonists A Patent Review (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1037 Exhibit: US Prosecution History of the 908 Patent
Document
PGR2022-00025, No. 1037 Exhibit - US Prosecution History of the 908 Patent (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1034 Exhibit: Shargel Applied Biopharmaceutics Pharmacokinetics 6th ed 2012
Document
PGR2022-00025, No. 1034 Exhibit - Shargel Applied Biopharmaceutics Pharmacokinetics 6th ed 2012 (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1010 Exhibit: US Patent Application Publication No 20060078623 to Dhoot et al
Document
PGR2022-00025, No. 1010 Exhibit - US Patent Application Publication No 20060078623 to Dhoot et al (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1024 Exhibit: Merke Congenital Adrenal Hyperplasia Due to 21 Hydroxylase Deficie...
Document
PGR2022-00025, No. 1024 Exhibit - Merke Congenital Adrenal Hyperplasia Due to 21 Hydroxylase Deficiency, (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1017 Exhibit: Speiser Congenital Adrenal Hyperplasia Due to Steroid 21 Hydroxyla...
Document
PGR2022-00025, No. 1017 Exhibit - Speiser Congenital Adrenal Hyperplasia Due to Steroid 21 Hydroxylase Deficiency (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1023 Exhibit: Microparticles Formulation as a Targeting Drug Delivery System, J Na...
Document
PGR2022-00025, No. 1023 Exhibit - Microparticles Formulation as a Targeting Drug Delivery System, J Nanomed Res (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
